Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 5/17/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Gary Frashier?

Gary E. Frashier

President and Founder

Management & Associates Inc

HQ Phone:  (813) 433-2000

Direct Phone: (210) ***-****direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Management & Associates Inc

720 Brooker Creek Boulevard

Oldsmar, Florida,34677

United States

Company Description

Management & Associates has made a personal and corporate commitment to maintain the highest standard of professional excellenceand ethics. Continuing education is an on-going structured process. | Our managers are fully licensed. You will find their knowledge... more

Find other employees at this company (13,822)

Background Information

Employment History

Executive Vice President

Millipore Corporation


Managing Partner

Targeted Technology


President and Chief Executive Officer of Waters Chromatography Subsidiary

Water and Associates LLC


Strategic Partner

SV Life Sciences


Chairman and Chief Executive Officer

OSI Pharmaceuticals , Inc.


Affiliations

MERRIMACK PHARMACEUTICALS INC

Founder


BioMed SA

Board Member


Achillion Pharmaceuticals , Inc.

Director


Metric Medical Devices Inc

Board Member


ViroXis Corporation

Board Member


Santalis Corporation

Advisor


StemBioSys , Inc.

Board Member


America Stem Cell , Inc.

Business Advisory Board Member


Boston Life Sciences , Inc.

Board Member


Inex Pharmaceuticals Corporation

Board Member


Sloan

Fellow


Massachusetts Institute of Technology

Member, Advisory Boards


Young Presidents' Organization Inc

Member


Xeris Pharmaceuticals , Inc.

Board Member


Education

B.S

Chemical Engineering

Texas Tech


M.B.A.

Massachusetts Institute


M.S.

Management

M.I.T


Web References(110 Total References)


Board of Directors | Metric

metricmd.com [cached]

Gary E. Frashier
Board of Directors Mr. Frashier is President and Principal of Management Associates, and he brings extensive experience in life science management, operations and transactions, having served as a CEO for twenty-four years in life sciences and specialty chemicals. Prior to the founding of Management Associates, Mr. Frashier served as Chief Executive Officer and Chairman of OSI Pharmaceuticals, and it was during his tenure at OSI that the leading genetic-based cancer drug, "Tarceva" was discovered and developed thru initial human Proof of Concept clinical trials. Mr. Frashier has raised over $250 million from a combination of equity financings and other sources, has organized many collaborations and joint programs with major pharmaceutical companies, and has served as a founder of several life science companies. Prior to OSI, Mr. Frashier served as President, International, and Executive Vice President of Millipore Corporation; President and CEO of Waters Corporation, the leader in liquid chromatography; and CEO of Genex Corporation, a protein engineering company. He has participated as a founder in organizing several biotechnology companies, including Merrimack Pharmaceuticals, Inc.; Eutropics, Inc.; America Stem Cell, Inc.; and Apex BioVentures Acquisition Corporation. He currently serves on the Board of Directors of Achillion Pharmaceuticals, Inc. (NASDAQ), ViroXis Corporation, Inc., and Metric Medical Devices, Inc., and he is an Advisor to Santalis Corporation and StemBioSys. He is a Strategic Partner in SV Life Sciences LP, a major venture capital company. He has served on numerous other private and public life science company Boards, including Maxim Pharmaceuticals, Tekmira Pharmaceuticals (Canada), Apex BioVentures Acquisition Corporation, Tanox, Inc., Cytoclonal Pharmaceuticals, Exegenics Pharmaceuticals, Aderis Pharmaceuticals, and Alseres Pharmaceuticals. Mr. Frashier has a B.S. in Chemical Engineering from Texas Tech University, which has designated him a "Distinguished Engineer Graduate," and an M.B.A. from the Massachusetts Institute of Technology, where he was selected as an "Alfred P. Sloan Fellow.


stembiosys.com

Gary E. Frashier
"StemBioSys has done an excellent job developing its unique stem cell technology. The company is ready to move to the next level." - Gary E. Frashier Gary Frashier's skill in the development and commercialization of life sciences technologies and companies is evident in his long list of highly productive investment rounds and profitable exits. As CEO of OSI Pharmaceuticals he oversaw the development of Tarceva, a cancer drug eventually marketed by Roche and Genentech and currently generating $1.7 billion in annual sales. OSI was acquired for $4 billion in 2010 and in addition Mr. Frashier has raised more than $250 million in equity and other sources for a wide variety of life science companies. His executive leadership experience includes CEO and president positions with Millipore Corp., Waters Corp. and Genex Corp. Mr. Frashier has founded or co-founded several biotechnology companies including Merrimack Pharmaceuticals, Eutropics and Apex BioVentures Acquisition Corp. He serves as a director or advisor with of many of these and other life science companies. Mr. Frashier is a strategic partner with SV Life Sciences, a major venture capital company. He also serves as president and principal of Management Associates. Mr. Frashier holds a B.S. in chemical engineering from Texas Tech University and an M.B.A. from the Massachusetts Institute of Technology.


Achillion Pharmaceuticals, Inc.: Board of Directors

www.achillion.com [cached]

Gary E. Frashier Director
Mr. Frashier joined Achillion's Board of Directors in March 2008. Formerly holding chief executive and/or chairman roles at OSI Pharmaceuticals, Millipore Corporation, Merrimack Pharmaceuticals and eXegenics, Mr. Frashier currently is principal with Management Associates, a life sciences consulting firm.


America Stem Cell

www.americastemcell.com [cached]

Gary Frashier, M.B.A Executive Chairman of the Board & Co-Program/Project Team Leader for the ASC 101 Development Program
Gary is the President and Principal of Management Associates and brings extensive experience in life science company transactions and commercial operations. Prior to founding Management Associates in 1999, Mr. Frashier served as President and Chief Executive Officer of OSI Pharmaceuticals, a drug discovery company, from 1990 through 1998, and also as its Chairman of the Board from 1997 to 2000. During his tenure at OSI, the leading cancer drug "Tarceva" was discovered by OSI and it is now sold together with Genentech and Roche. Gary was instrumental in establishing strategic alliances with Pfizer, Hoechst, Sankyo, Roche and American Home Products and raised over $150 million from a combination of equity financings, grant awards, milestone payments and up-front fees.


America Stem Cell Inc: Management Team

www.americastemcell.com [cached]

Gary Frashier, M.B.A Executive Chairman of the Board & Co-Program/Project Team Leader for the ASC 101 Development Program
Gary is the President and Principal of Management Associates and brings extensive experience in life science company transactions and commercial operations. Prior to founding Management Associates in 1999, Mr. Frashier served as President and Chief Executive Officer of OSI Pharmaceuticals, a drug discovery company, from 1990 through 1998, and also as its Chairman of the Board from 1997 to 2000. During his tenure at OSI, the leading cancer drug "Tarceva" was discovered by OSI and it is now sold together with Genentech and Roche. Gary was instrumental in establishing strategic alliances with Pfizer, Hoechst, Sankyo, Roche and American Home Products and raised over $150 million from a combination of equity financings, grant awards, milestone payments and up-front fees.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory